- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: (H) T-L14
Total 5602 results
-
Sunshine Lake Pharma Co., Ltd.Active, not recruiting
-
Mylan Inc.Mylan Bertek PharmaceuticalsTerminated
-
Hutchison Medipharma LimitedCovanceCompleted
-
Millennium Pharmaceuticals, Inc.CompletedHealthy VolunteersUnited States
-
Case Comprehensive Cancer CenterCompletedProstate CancerUnited States
-
Agios Pharmaceuticals, Inc.Completed
-
Universitaire Ziekenhuizen KU LeuvenCompletedKidney Transplantation | Drug InteractionsBelgium
-
Bristol-Myers SquibbCompletedMalignancies MultipleUnited States
-
Boehringer IngelheimCompleted
-
Genentech, Inc.CompletedHealthy VolunteerUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedLung Diseases | Respiratory Distress Syndrome, AdultUnited States, Canada
-
Anders Rane, MD, PhD, Senior professorKarolinska University HospitalCompletedBacterial Infections and Mycoses | Ductus Arteriosis, PatentSweden
-
Modern Biosciences LtdRecruitingPharmacokineticsUnited Kingdom
-
Asceneuron S.A.RecruitingDrug Drug InteractionNetherlands
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Not yet recruiting
-
Boehringer IngelheimRecruiting
-
Hoffmann-La RocheActive, not recruitingBreast NeoplasmsUnited States, Israel, Korea, Republic of
-
KBP BiosciencesCovanceCompletedHealthy | Drug Drug InteractionUnited States
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdCompleted
-
Abbisko Therapeutics Co, LtdEnrolling by invitationHealthy SubjectsChina
-
Jiangsu Aosaikang Pharmaceutical Co., Ltd.CompletedLocally Advanced or Metastatic NSCLCChina
-
Eli Lilly and CompanyCompleted
-
Impact Therapeutics, Inc.Completed
-
PfizerMedivation, Inc.CompletedAdvanced Solid TumorsRussian Federation, Hungary, Moldova, Republic of, Poland
-
Janssen Research & Development, LLCCompleted
-
Eli Lilly and CompanyCompleted
-
Genentech, Inc.CompletedMetastatic Melanoma, BRAF V600 Mutation PositiveKorea, Republic of, Russian Federation, Israel, United States
-
Shouyao Holdings (Beijing) Co. LTDNot yet recruiting
-
Dizal PharmaceuticalsRecruitingHealthy SubjectsUnited States
-
Basilea PharmaceuticaCompletedFungal InfectionNetherlands
-
CelgeneTerminatedNeoplasms | Lymphoma, Non-HodgkinFrance, Italy, Japan, Spain, United Kingdom
-
BeiGeneCompletedB-cell MalignanciesAustralia
-
Epizyme, Inc.CompletedSolid Tumor | Mesothelioma | Rhabdoid Tumor | Hematologic Malignancy | Advanced Malignancies | Synovial Sarcoma | Renal Medullary Carcinoma | Diffuse Large B-Cell Lymphoma (DLBCL) | Follicular Lymphoma (FL) | Non-Hodgkin Lymphoma (NHL) | All Malignancies | Epithelioid Sarcoma (ES)Spain, United States
-
Jazz PharmaceuticalsCompleted
-
Ciceri FabioCompletedMyelodysplastic Syndromes | Fungal Infection | Graft Vs Host Disease | Leukemia, Acute | Transplant-Related Hematologic MalignancyItaly
-
Bristol-Myers SquibbCompletedHealthy ParticipantsUnited States
-
AnHeart Therapeutics Inc.Completed
-
Eli Lilly and CompanyLoxo Oncology, Inc.Completed
-
Azienda Ospedaliero, Universitaria PisanaCompletedStem Cell Transplant ComplicationsItaly
-
Enanta Pharmaceuticals, IncCompletedNASH - Nonalcoholic SteatohepatitisUnited States
-
BayerOrion Corporation, Orion PharmaCompletedBiological AvailabilityGermany
-
Sanofi Pasteur, a Sanofi CompanyCompletedInfluenzaUnited States
-
Vanda PharmaceuticalsCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Boryung Pharmaceutical Co., LtdCompleted
-
National Cancer Institute (NCI)RecruitingLung Adenocarcinoma | Lung Non-Small Cell Carcinoma | Stage IV Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage IIIC Lung Cancer AJCC v8 | Lung Adenosquamous CarcinomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)Not yet recruitingPlasma Cell Myeloma | Refractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Adult Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States